Disease Overview：Subarachnoid Hemorrhage（SAH）
Subarachnoid hemorrhage (SAH) is a life-threatening neurological emergency characterized by bleeding into the subarachnoid space—the cerebrospinal fluid–filled area surrounding the brain and spinal cord. Most commonly caused by rupture of a cerebral aneurysm, SAH presents acutely with sudden, severe headache (“thunderclap headache”), neck stiffness, photophobia, altered consciousness, or focal neurological deficits. Prompt diagnosis via non-contrast CT scan—followed by CT angiography or digital subtraction angiography (DSA)—is critical to identify the source and guide intervention. Management involves securing the aneurysm via endovascular coiling or microsurgical clipping, controlling intracranial pressure, preventing rebleeding and vasospasm, and managing complications such as hydrocephalus or delayed cerebral ischemia. Mortality remains high without timely, specialized care, underscoring the need for multidisciplinary neurocritical support.
China offers distinct advantages in SAH management: its leading neurovascular centers—many affiliated with top-tier academic hospitals—employ internationally trained neurointerventionalists and neurosurgeons with extensive experience in complex aneurysm treatment. Advanced imaging platforms (e.g., 3T MRI, biplane DSA systems), intraoperative neuromonitoring, and neuro-intensive care units meet global standards. Clinical outcomes align closely with Western benchmarks, with published series reporting favorable functional recovery rates (>65% good outcome at 6 months) and low procedural complication rates. Crucially, comprehensive SAH care—including diagnostics, acute intervention, rehabilitation, and follow-up—is significantly more cost-effective than in the US, UK, or Germany—often at 40–60% lower total expense without compromising quality. As a dedicated medical tourism agency, we facilitate seamless access to these high-performing centers: coordinating appointments with certified specialists, verifying transparent all-inclusive pricing, arranging visas and accommodations, and providing bilingual clinical liaison and post-discharge support—ensuring international patients receive timely, evidence-based, and compassionate care.
Subarachnoid Hemorrhage: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Subarachnoid Hemorrhage (Neurology Department)
Non-Surgical / Conservative Management
*Indicated for Hunt-Hess Grade I–II, stable aneurysm-negative SAH, or patients unfit for intervention.*
- •Target Criteria: Confirmed non-aneurysmal SAH (CT/CTA negative), mild clinical grade, no rebleeding risk factors.
- •Core Medications:
- Antihypertensives (labetalol IV/oral): ¥25–¥40/day → $3.50–$5.60/day - Analgesics (acetaminophen IV): ¥18–¥32/day → $2.50–$4.50/day
- •Monitoring & Labs:
- CBC, electrolytes, coagulation panel (per set): ¥180–¥260 → $25–$36 - Serial CT head (each): ¥320–¥480 → $45–$67
Surgical / Interventional Management
*Indicated for confirmed ruptured intracranial aneurysm, Hunt-Hess III–V, or rebleeding.*
- •Eligibility: Confirmed aneurysm on CTA/MRA/DSA; age <80 with acceptable surgical risk; absence of irreversible brainstem herniation.
- •Preoperative Workup (mandatory):
- Cardiopulmonary evaluation (ECG, echo, PFTs): ¥1,100–¥1,600 → $154–$224
- •Procedure Costs (single-session, inclusive of anesthesia, OR, ICU admission × 3 days):
- Surgical Clipping (craniotomy): ¥75,000–¥105,000 → $10,500–$14,700 - *Note: Costs include stent-assisted coiling or flow diversion if required.*
Special / Complex Condition Management
- •Rebleeding or Vasospasm Complications:
- Intrathecal thrombolytic (tPA) infusion guidance): ¥15,000–¥22,000 → $2,100–$3,080
- •Delayed Cerebral Ischemia (DCI) with Refractory Vasospasm:
Quick Selection Guide
- •Young patient (<60), good functional status, aneurysm accessible by endovascular route: Coiling — optimal safety profile, shorter recovery.
- •Patient >75 years, comorbid cardiopulmonary disease, or contraindication to antiplatelets: Conservative management + strict BP control — avoids procedural risks.
- •Large/complex aneurysm (e.g., basilar apex, fusiform), prior failed coiling, or need for bypass: Clipping — higher durability, lower retreatment rate.
- •Budget-constrained patient (<$5,000 USD available): Conservative pathway with nimodipine + serial CT monitoring — avoids high-cost interventions unless rebleeding occurs.
- •Hunt-Hess IV–V with early herniation signs: Urgent coiling/clipping only if reversible compression evident on imaging — otherwise palliative neurocritical care (¥2,500–¥4,000/day → $350–$560/day).
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Subarachnoid Hemorrhage Medical Vacation Packages
Curated transparent all-inclusive packages combining Subarachnoid Hemorrhage treatment with China top medical destinations:
